125 Baseline bone metabolism markers as predictors for progression-free survival of patients with treatment-naïve bone-metastatic prostate cancer treated with zoledronic acid plus combined androgen blockade

✍ Scribed by M. Nozawa; T. Inagaki; K. Nagao; T. Nishioka; T. Komura; A. Esa; M. Kitagawa; M. Imanishi; Y. Uekado; T. Ogawa; H. Kajikawa; S. Uejima; H. Matsuyama; I. Hara; H. Uemura

• Book ID: 119624061
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 19 KB
• Volume: 11
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/s1569-9056(12)60124-9